Takeshi Ikeuchi
Overview
Explore the profile of Takeshi Ikeuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
236
Citations
4357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishikawa M, Takeda A, Miyazawa N, Hara N, Ishii K, Ikeuchi T, et al.
Intern Med
. 2025 Mar;
PMID: 40058853
A 47-year-old man with a family history of juvenile dementia in his mother presented with memory loss and cognitive decline. Neuropsychological tests revealed impaired orientation, working memory, and apraxia. Magnetic...
2.
Hongo S, Ikeda T, Tada M, Aida R, Ozawa T, Hara N, et al.
Neuropathol Appl Neurobiol
. 2025 Feb;
51(1):e70006.
PMID: 39996377
No abstract available.
3.
Bateman R, Li Y, McDade E, Llibre-Guerra J, Clifford D, Atri A, et al.
medRxiv
. 2025 Feb;
PMID: 39974075
Background: Amyloid-plaque removal by monoclonal antibody therapies slows clinical progression in symptomatic Alzheimer's disease; however, the potential for delaying the onset of clinical symptoms in asymptomatic people is unknown. The...
4.
Liu H, Marsh T, Shi X, Renton A, Bowling K, Ziegemeier E, et al.
Brain
. 2025 Feb;
PMID: 39903689
We present a comprehensive global analysis of genetic variants associated with autosomal-dominant Alzheimer's disease (ADAD). A total of 550 variants in the APP, PSEN1, and PSEN2 genes were identified, of...
5.
Shibata Y, Chang H, Nakamura K, Yamada S, Matsushima M, Saigoh K, et al.
Rinsho Shinkeigaku
. 2025 Jan;
65(2):101-107.
PMID: 39864867
In Japan, there are no nationwide guidelines for presymptomatic testing for hereditary neuromuscular diseases. Although each institution has been dealing with this situation by using their own procedures to date,...
6.
Ono Y, Takigawa H, Takekoshi A, Yoshikura N, Aiba I, Hanajima R, et al.
Parkinsonism Relat Disord
. 2025 Jan;
107289.
PMID: 39843325
Serum anti-IgLON5 antibodies, which were tested in 223 patients meeting the diagnostic criteria for progressive supranuclear palsy/corticobasal syndrome (PSP/CBS), were negative in all patients. Our study suggests that the frequency...
7.
Hatakeyama Y, Kimura A, Tsuboguchi S, Ratanov M, Nakamura K, Hatakeyama M, et al.
Eur J Nucl Med Mol Imaging
. 2024 Dec;
PMID: 39699685
No abstract available.
8.
Akiyama N, Kanazawa M, Kasuga K, Hatakeyama M, Ikeuchi T, Onodera O
Mov Disord Clin Pract
. 2024 Dec;
PMID: 39688304
Background: Progressive supranuclear palsy (PSP) is a major atypical parkinsonism. Because diagnosis based on the cardinal clinical features is often difficult, misdiagnosis with Parkinson's disease (PD) and multiple system atrophy...
9.
Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease
Zhou X, Cao H, Jiang Y, Chen Y, Zhong H, Fu W, et al.
Alzheimers Dement
. 2024 Dec;
21(1):e14214.
PMID: 39655505
Introduction: The SORL1 locus exhibits protective effects against Alzheimer's disease (AD) across ancestries, yet systematic studies in diverse populations are sparse. Methods: Logistic regression identified AD-associated SORL1 haplotypes in East...
10.
Hojo M, Soma N, Yamada K, Kobayashi Y, Miura M, Fujii H, et al.
Hum Genome Var
. 2024 Dec;
11(1):45.
PMID: 39627236
Bryant-Li-Bhoj syndrome (BLBS; OMIM # 619720, 619721), caused by germline H3F3A and H3F3B variants encoding histone H3.3, is characterized by mild to severe developmental delay, intellectual disability, failure to thrive,...